External resources
Current NHS consultant posts held
Consultant Urological Surgeon
St James's University Hospital
Leeds Teaching Hospitals NHS Trust
Beckett Street
Ls9 7TF
Research interests
My main research interest is prostate cancer and currently hold the following research positions:
- STAMPEDE trial management group
- RADICALS trial management group
- PERSONAL trial chief investigator
Personal interests
Cycling
Publications
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. The Lancet 2020
Decision regret in men living with and beyond non-metastatic prostate cancer in the UK: a population-based patient-reported outcome study. Psycho-oncology 2020
Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group. Journal of Bone Oncology 2020
Autonomous Tissue Retraction in Robotic Assisted Minimally Invasive Surgery A Feasibility Study. IEEE Robotics and Automation Letters 2020
Patterns of lymph node failure in recurrent prostate cancer patients post radical prostatectomy and implications for salvage therapies. Advances in Radiation Oncology 2020
Toward autonomous tissue retraction in robotic assisted minimally invasive surgery. European Urology Open Science 2020
Book Chapter. Haptics in Surgical Robots, Culmer, P, Alazmani A, Mushtaq F, Cross, W and Jayne D in Handbook of Robotic and Image-guided Surgery. Published Sept 2019
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. Ann Oncol 2019
Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study. BMC Cancer 2019
Abiraterone in "High-" and ‘Low-risk’ Metastatic Hormone-sensitive Prostate Cancer. Eur Urol Published Online First: 22 August 2019
The psychological impact of being on a monitoring pathway for localised prostate cancer: A UK-wide mixed methods study. Psychooncology 2019
Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom. Eur Urol Published Online First: 3 May 2019
Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement. BJU Int 2019
• Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study. Lancet Oncol 2019
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness. European Urology Oncology 2018
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial. Lancet 2018